CSPC Pharma Slumps on Speculation Drug Is on China Watch List

(Bloomberg) -- CSPC Pharmaceutical Group Ltd.’s shares logged their biggest decline since Feb. 19 on speculation that a component of the Chinese drugmaker’s key product has been put on a government...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.